0 followers
Tiaki Therapeutics is developing first-in-class therapeutics that target microglia, the immune cells of the brain, to address inflammatory-driven CNS disorders and protect cognitive function.
Suzanne Bruhn
Orchid
1 follower
Thermo Fisher Scientific
180 followers
Genentech
162 followers
Gilead Sciences
136 followers
Biogen
123 followers
Regeneron
104 followers
Vertex Pharmaceuticals
66 followers
Agilent Technologies
71 followers
BioMarin Pharmaceutical
37 followers
Natera
16 followers
10X Genomics
15 followers
Explore companies